financetom
Business
financetom
/
Business
/
Canadian Cannabis Giant Sets Stage For Growth With $18.5M Public Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canadian Cannabis Giant Sets Stage For Growth With $18.5M Public Offering
Mar 29, 2024 5:48 AM

OrganiGram Holdings Inc. ( OGI ) , a Toronto-based cannabis company, has officially announced the pricing of its overnight marketed public offering. 

In collaboration with ATB Securities Inc. as the lead underwriter, OrganiGram ( OGI ) is set to offer 7,740,000 units at CA$3.23 ($2.39) each. This decision is poised to inject approximately CA$25 million ($18.5 million) in gross proceeds, signaling a significant leap forward for the company's financial and growth strategy.

A Closer Look At The Offering’s Structure

The offering includes an over-allotment option, allowing underwriters to acquire up to 1,161,000 additional units. This flexibility aims to stabilize the market post-offering and address potential over-allotments. Also, each unit in this offering comprises one common share and a half warrant, with each full warrant enabling the purchase of one common share at CA$3.65 over the next four years, subject to adjustments.

Top executives leading some of the largest cannabis operators are slated to share valuable advice and insights at the upcoming Benzinga Cannabis Capital Conference in Florida on April 16-17. The two-day event that returns to The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow.

Regulatory Approvals And Investor Documentation

Slated for closure around April 2, 2024, this financial endeavor is contingent upon standard market conditions and regulatory nods, including the Toronto Stock Exchange and and NASDAQ’s approval. The anticipated proceeds have been earmarked for propelling OGI's growth initiatives alongside covering general corporate expenses.

Prospective investors are advised to review the offering’s detailed documentation, accessible through SEDAR+ and EDGAR. Moreover, this documentation includes a prospectus supplement and a base shelf prospectus, providing a comprehensive overview of Organigram’s strategic intentions and financial outlook.

Initial Market Response

The initial market response to Organigram’s public offering was a downturn in its stock value. This event follows closely on the heels of the company’s latest earnings report, which highlighted a 16% year-over-year decrease in revenue for the first quarter of 2024, marking a pivotal moment in OGI's financial trajectory.

There's no better time to dive deeper into the ever-changing landscape of cannabis investing. Join us at the upcoming Benzinga Cannabis Capital Conference in Florida at the new Hollywood venue on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn, and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world. Get your tickets now on bzcannabis.com – Prices will increase very soon!

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novartis Gets Swiss Approval for Malaria Drug for Infants
Novartis Gets Swiss Approval for Malaria Drug for Infants
Jul 8, 2025
06:07 AM EDT, 07/08/2025 (MT Newswires) -- Novartis ( NVS ) said Tuesday its Coartem Baby has received approval from Swissmedic for the treatment of malaria for newborns and young infants. The approval was based on a phase 2/3 study, which looked into a new ratio and dose of Coartem to account for metabolic differences in babies under five kilograms....
Analysis-Activist investors set to push for changes as dealmaking picks up
Analysis-Activist investors set to push for changes as dealmaking picks up
Jul 8, 2025
NEW YORK/FRANKFURT (Reuters) -Activist shareholders are poised to push harder for corporate changes in the coming months, finding fresh confidence to launch campaigns as the pace of dealmaking picks up again. Bankers, lawyers, and investors forecast a spike in fights over corporate leadership, operational improvements and spin-offs in the second half of 2025. Many global corporations will gird for costly...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Market Chatter: XP Sues Grizzly Research Over Report
Market Chatter: XP Sues Grizzly Research Over Report
Jul 8, 2025
06:11 AM EDT, 07/08/2025 (MT Newswires) -- XP (XP) filed a defamation lawsuit Monday against short seller Grizzly Research over a March 12 report that accused the Brazilian fintech company of running a Ponzi scheme, Reuters reported late Monday. XP said in the complaint that it suffered damages totaling more than $100 million as a result of the report, Reuters...
Copyright 2023-2026 - www.financetom.com All Rights Reserved